In the media :

Wednesday 21 February 2018 - Becker's Hospital Review:   Tumor microenvironment is a powerful companion diagnostic for cancer immunotherapy applications    |     Wednesday 17 January 2018 - Labiotech.eu:   HalioDx Closes a €18.5M Series B to Boost Colon Cancer Diagnostics    |     Wednesday 17 January 2018 - FierceBiotech:   HalioDx raises $23M to expand I-O test suite, enter U.S.    |     Monday 20 November 2017 - L'Espace Datapresse:   LANCEMENT DE PIONEER, UN GRAND PROJET INTERNATIONAL DE RECHERCHE CONTRE LE CANCER DU POUMON    |     Thursday 09 November 2017 - Medical Health News:   NCRI 2017: Take home messages from the conference .    |